# ClinicalTrials.gov record NCT04026256

> PeptideScanner retained ClinicalTrials.gov record NCT04026256 at 2026-07-30T19:09:38.366Z. Its registry update date was 2023-08-02, and PeptideScanner's reviewed identity mapping was teriparatide.

- Evidence object: `story:clinicaltrials-gov-nct04026256-teriparatide:v1`
- Evidence domain: Clinical trials
- Date in source: 2023-08-02
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-14
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct04026256-teriparatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct04026256-teriparatide-v1.json
- Content SHA-256: `1db7bf375a6b740f6485881b5b31c8432e00fab775d4284164d7532c0930c72c`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT04026256 ([`ctg-observation-nct04026256-2023-08-02-6fecc359c524`](#source-ctg-observation-nct04026256-2023-08-02-6fecc359c524))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT04026256 at 2026-07-30T19:09:38.366Z. Its registry update date was 2023-08-02, and PeptideScanner's reviewed identity mapping was teriparatide. ([`ctg-observation-nct04026256-2023-08-02-6fecc359c524`](#source-ctg-observation-nct04026256-2023-08-02-6fecc359c524))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT04026256 at 2026-07-30T19:09:38.366Z. Its registry update date was 2023-08-02, and PeptideScanner's reviewed identity mapping was teriparatide. ([`ctg-observation-nct04026256-2023-08-02-6fecc359c524`](#source-ctg-observation-nct04026256-2023-08-02-6fecc359c524))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct04026256-2023-08-02-6fecc359c524`](#source-ctg-observation-nct04026256-2023-08-02-6fecc359c524))

## Sources

<a id="source-ctg-observation-nct04026256-2023-08-02-6fecc359c524"></a>
- **ClinicalTrials.gov record NCT04026256 · retained source version 2023-08-02:6fecc359c524f9c60cf1ecd8ea992ec474da0a9623705493d7829b00a7024da4** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT04026256) (`ctg-observation-nct04026256-2023-08-02-6fecc359c524`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT04026256." Version 1, published 2026-08-14. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct04026256-teriparatide-v1.json SHA-256: 1db7bf375a6b740f6485881b5b31c8432e00fab775d4284164d7532c0930c72c.